US$ 22.31
crohn's disease and glp-1 for Disease: Current Evidence Treatment Options Weight Loss Medications & IBD
Description
These receptor-specific interactions may contribute to the G protein specificity of GLP-2R

doi: 10.1038/304368a0 18 DAlessioD

Appetite suppression requires higher receptor occupancy than these doses provide

Medical supervision is essential

Diabetologia 53(suppl 1):S341 Adame J, Cohen PR (1996) Eosinophilic panniculitis: diagnostic considerations and evaluation

For patients with diabetes, hypoglycemia risk increases when GLP-1 agents are combined with insulin or sulfonylureas